Buscar

04/03/2026 White matter microstructure differences in obstructive sleep apnea severity groups assessed by diffusion tensor metrics and biophysical modeling
Figueredo, LF, Chen, JY, Gaggi, NL, Song, XT, Jacobs, T, Silva-Albornoz, G, Pehel, S, Gonzalez, M, Badia, SG, Rosenzweig, I, Naismith, SL, Ramos-Cejudo, J, Gills, J, Ayappa, I, Rapoport, DM, Kam, K, Mullins, AE, Parekh, A, Varga, AW, Bubu, OM, Blessing, E, Novikov, DS, Fieremans, E, Osorio, RS. White matter microstructure differences in obstructive sleep apnea severity groups assessed by diffusion tensor metrics and biophysical modeling. Scientific Reports. 2026; 16(1)DOI:10.1038/s41598-026-39162-7. PMID:41781414. IF:3.900(Q1/2D).
01/04/2026 Metabolic brain networks in dementia with Lewy bodies: from prodromal to manifest disease stages
Perovnik, M, Simoncic, U, Jamsek, J, Kramberger, MG, Brumberg, J, Meyer, PT, Perani, D, Caminiti, SP, Brendel, M, Stockbauer, AC, Camacho, V, Alcolea, D, Vandenberghe, R, Van Laere, K, Ko, JH, Lee, CS, Pardini, M, Lombardo, L, Padovani, A, Pilotto, A, Ochoa-Figueroa, MA, Davidsson, A, Cháfer-Pericás, C, Alvarez-Sánchez, L, Garibotto, V, Lemstra, AW, Ferreira, D, Morbelli, SD, Tang, CC, Eidelberg, D, Trost, M. Metabolic brain networks in dementia with Lewy bodies: from prodromal to manifest disease stages. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. 2026; 97(4)DOI:10.1136/jnnp-2025-336935. PMID:41344886. IF:7.500(Q1/1D).
04/02/2026 Temporal dynamics of white matter hyperintensities related to Alzheimer's disease in adults with Down syndrome
Morcillo-Nieto, AO, Rozalem-Aranha, M, Maure-Blesa, L, Rodríguez-Baz, I, Arriola-Infante, JE, Franquesa-Mullerat, M, Zsadanyi, SE, Vaqué-Alcázar, L, Parra, JA, Zhao, ZL, Arranz, J, Videla, L, Barroeta, I, Soriano, LD, Benejam, B, Fernández, S, Hernandez, AS, Pertierra, L, Giménez, S, Alcolea, D, Belbin, O, Lleó, A, Carmona-Iragui, M, Fortea, J, Bejanin, A. Temporal dynamics of white matter hyperintensities related to Alzheimer's disease in adults with Down syndrome. ALZHEIMERS & DEMENTIA. 2026; 22(2)DOI:10.1002/alz.71157. PMID:41639041. IF:11.100(Q1/1D).
01/03/2026 A quantitative DOPA decarboxylase biomarker for diagnosis in Lewy body disorders
Bolsewig, K, Bellomo, G, Hok-A-Hin, YS, Al Idrissi, I, Vermunt, L, Lleó, A, Alcolea, D, Sieben, A, Engelborghs, S, Simonsen, AH, Hasselbalch, SG, Bech, S, Morrema, THJ, Hoozemans, JJM, Bol, JGJM, Van Alphen, J, Gaetani, L, Chiasserini, D, Paoletti, FP, Parnetti, L, Kang, SW, Lee, YG, Jeon, S, Lee, AH, Jeon, S, Ye, BS, Milán, MD, Van Der Flier, WM, Van De Berg, WDJ, Lemstra, AW, Willemse, EAJ, Teunissen, CE. A quantitative DOPA decarboxylase biomarker for diagnosis in Lewy body disorders. NATURE MEDICINE. 2026; 32(3)DOI:10.1038/s41591-026-04212-0. PMID:41699128. IF:50.000(Q1/1D).
17/02/2026 Factors impacting survival in individuals with Down syndrome-associated Alzheimer's disease
Benejam, B, McCarron, M, Carmona-Iragui, M, Dunne, P, Maure-Blesa, L, Altuna, M, Arranz, J, Barroeta, I, Bejanin, A, Soriano, LD, Fernández, S, Giménez, S, Lleó, A, Lynch, L, Mccallion, P, Mulryan, N, Pertierra, L, Rebillat, A, Rodríguez-Baz, I, Hernández, AS, Vaqué-Alcázar, L, Videla, L, Wormald, A, Fortea, J, McGlinchey, E. Factors impacting survival in individuals with Down syndrome-associated Alzheimer's disease. ALZHEIMERS & DEMENTIA. 2026; 22(2)DOI:10.1002/alz.71156. PMID:41700075. IF:11.100(Q1/1D).
26/03/2026 Impaired semantic word learning in primary progressive aphasia
Olivé, G, Cardona, G, Porto, MF, Gerloff, A, Marqués-Kiderle, S, Filella-Mercè, J, Sala, I, Sánchez-Saudinós, MB, Armas, P, Peñaloza, C, Grasso, SM, Bejanin, A, Alcolea, D, Illan-Gala, I, Fortea, J, Lleó, A, Vaquero, L, Rodríguez-Fornells, A, Santos-Santos, MA. Impaired semantic word learning in primary progressive aphasia. Brain Structure & Function. 2026; 231(3)DOI:10.1007/s00429-026-03081-0. PMID:41882244. IF:2.900(Q1/1D).